WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'1701 Infant (under 12 months) mortality rate: 792
GDP / capita (US$): 2'3421 Child (under 5 years) mortality rate: 1272

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 21'700  21'156  20'624  20'104  19'595  15'928  12'070  8'932 
Births 820  809  798  786  774  658  540  412 
Surviving infants 759  747  735  723  711  600  490  370 
Pop. less than 5 years 3'572  3'510  3'441  3'379  3'320  2'758  2'258  1'635 
Pop. less than 15 years 9'359  9'157  8'954  8'769  8'588  7'212  5'586  3'991 
Female 15-49 years 5'133  4'988  4'847  4'703  4'561  3'564  2'609  1'971 

Number of reported case

(Click for retrospective incidence data for Cameroon)
Diphtheria
Japanese encephalitis
Measles 609  504  240  251  495  14'629  21'150 
Mumps
Pertussis 5'498 
Polio* 38  255 
Rubella 147  106  48  33  78 
Rubella (CRS)
Tetanus (neonatal) 23  31  29  39  43  279  382 
Tetanus (total) 93  83  72  65  279  382 
Yellow fever 31  29  16  173 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Cameroon)
Vaccine year result method % card seen                                                
BCG 2010  87  DHS   57.0  81  80  83  79  86  69  52 
DTP1 2010  86  DHS   57.0  94  90  92  88  93  54 
DTP3 2010  68  DHS   57.0  85  82  84  80  84  53  36 
HepB_BD         
HepB3 2010  65  DHS   57.0  85  82  84  80  84 
Hib3          85  82  84  80 
JapEnc         
MCV 2010  71  DHS   57.0  82  76  79  74  80  49  36 
MCV2         
PCV1          92  89 
PCV3          84  70 
Pol3 2010  70  DHS   57.0  85  80  83  79  82  49  34 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  59  DHS   57.0  65  69  74  73  76  40  12 
PAB         
VAD1          73  76  85  83  99* 
YFV 2010  69  DHS   57.0  80  75  79  72  77 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Cameroon)
BCG 81  80  83  81  91  78  76 
DTP1 94  90  92  88  93  66  70 
DTP3 85  82  84  80  84  62  48 
HepB3 85  82  84  80  84 
Hib3 85  82  84  80 
MCV 82  76  79  74  80  49  56 
PAB 85  75  91  91  86  54  19 
PCV3 84  23 
Pol3 85  80  83  79  82  57  54 
Rota_last
YFV 80  75  79  72  77 

Number of districts in the country 181  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 48
From 80 to 89% 27
From 50 to 79% 25
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes from 2014
TT 1st contact; +1, +6 months; +1, +2 years; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; 6-59 months and postpartum
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2007-2011  2007-2011  2007-2011    2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 169  179  112  NA      167 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  NA  No         

System performance

Total number of districts in country number 181  179  179  173  173  171  167 
Nº districts with DTP3 coverage >=80% number 135  118  116  89  103  95  76 
% of districts with DTP3 coverage >=80% From 0 to 100% 75  66  65  51  60  56  46 
Nº districts with measles (MCV1) coverage >=95% number 51  33  32  18  36     
% of districts with MCV1 coverage >=95% From 0 to 100% 28  18  18  10  21     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  No  No  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 13  96  34  51  40  20 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.